GO:0150107 positive regulation of protein localization to cell-cell junction: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0150107 describes any process that activates or increases the frequency, rate or extent of protein localization to cell-cell junction.
• Cell-cell junctions are dynamic protein complexes that maintain epithelial integrity, and their localized mRNA regulation is required for junction assembly and barrier function.
• Junction proteins such as claudins, cadherins, and scaffold molecules must be delivered to specific membrane domains, a process controlled by localized translation and trafficking.
• Disruption of protein localization to junctions contributes to barrier dysfunction in sepsis and to cancer progression, including claudin18.2-positive gastric cancer.
• Astrocyte-secreted factors such as neurocan control inhibitory synapse formation, a specialized cell-cell junction, through localized protein delivery.
• CRISPR knockout, knock-in, and overexpression models enable causal testing of genes that regulate junctional protein localization.
Description
GO:0150107, positive regulation of protein localization to cell-cell junction, is a biological process term that captures any mechanism that increases the delivery or retention of proteins at junctions between cells. Cell-cell junctions are not static structures; they require continuous supply of newly synthesized and recycled proteins to maintain epithelial and endothelial barriers. The term is distinct from general protein localization because it specifically refers to positive regulation of the frequency, rate, or extent of protein accumulation at cell-cell contacts. Researchers study this process to understand tissue integrity, barrier function, and how junctional defects contribute to diseases such as sepsis and cancer. Recent work has shown that localized regulation of cell junction mRNAs is required for epithelial cell integrity, highlighting the importance of spatiotemporal control in this process. In parallel, alternative translation initiation can produce synaptic organizer proteoforms with distinct localization, illustrating how protein isoform diversity impacts junctional targeting. This article integrates the QuickGO definition with verified PubMed literature to provide a research-grade overview of GO:0150107, its mechanisms, key genes, disease relevance, and experimental models.
positive regulation of protein localization to cell-cell junction At A Glance
| GO ID | GO:0150107 |
|---|---|
| GO term | positive regulation of protein localization to cell-cell junction |
| Ontology | biological_process |
| Synonym | None |
| Major function | Increases the frequency, rate or extent of protein localization to cell-cell junctions |
| Related process | Cell-cell junction assembly, epithelial barrier maintenance |
| Cellular context | Epithelial cells, endothelial cells, astrocytes, neurons |
| Disease relevance | Sepsis-associated barrier dysfunction, cancer, synaptic disorders |
What Is GO:0150107?
According to the Gene Ontology, GO:0150107 (positive regulation of protein localization to cell-cell junction) is defined as any process that activates or increases the frequency, rate or extent of protein localization to cell-cell junction. In other words, it encompasses molecular events that promote the movement, anchoring, or accumulation of proteins at sites where adjacent cells contact each other. This includes signaling pathways that trigger junction assembly, localized translation of junctional mRNAs, and trafficking mechanisms that deliver proteins to the junctional membrane domain.
Why Is positive regulation of protein localization to cell-cell junction Important in Cell Biology?
Understanding positive regulation of protein localization to cell-cell junction is critical because junctional protein delivery is a prerequisite for tissue barrier function, cell polarity, and intercellular communication. Defects in this process can lead to loss of epithelial integrity, as seen in sepsis where neutrophil extracellular traps impair intestinal barrier functions via TLR9-mediated endoplasmic reticulum stress. In cancer, junctional proteins such as claudin18.2 are therapeutic targets, and their localization to cell-cell junctions influences tumor behavior and drug response. Moreover, specialized junctions like inhibitory synapses depend on astrocyte-secreted factors such as neurocan to control formation and function, linking this GO term to synaptic regulation. Thus, GO:0150107 sits at the intersection of cell biology, immunology, and neurobiology, making it a high-value target for mechanistic and translational research.
• Maintains epithelial and endothelial barrier integrity by ensuring junctional proteins reach cell-cell contacts.
• Its dysregulation contributes to intestinal barrier dysfunction in sepsis through TLR9-mediated ER stress.
• Junctional protein localization affects cancer progression and targeted therapy, as seen with claudin18.2 in gastric cancer.
• Astrocyte-secreted neurocan controls inhibitory synapse formation, a specialized cell-cell junction process.
• Localized mRNA regulation at junctions is required for epithelial cell integrity, revealing post-transcriptional control layers.
• Alternative translation initiation generates proteoforms with distinct localization, impacting junctional targeting.
• HCN1 channels enhance evoked GABA release from parvalbumin-positive interneurons, linking junctional signaling to neural circuits.
• Disruption of junctional protein delivery is implicated in inflammatory and infectious diseases.
• CRISPR-based models allow causal dissection of genes regulating junctional protein localization.
• The process is relevant to drug development, including monoclonal antibodies against junctional targets.
What Happens During positive regulation of protein localization to cell-cell junction?
Initiation and signaling at the junction
In simple terms: Cells receive signals that tell them to build or strengthen contacts with neighboring cells.
Positive regulation begins with extracellular or intracellular cues that activate signaling pathways promoting junction assembly. For example, in epithelial cells, localized regulation of cell junction mRNAs is required for integrity, suggesting that signaling events trigger the localized translation of junctional components. Astrocyte-secreted neurocan controls inhibitory synapse formation, indicating that secreted factors can initiate specialized junction assembly in the nervous system. These initial signals set the stage for directed protein delivery to cell-cell contacts.
Localized mRNA translation and protein synthesis
In simple terms: Messenger RNAs for junction proteins are translated right at the junction site.
A key mechanism for positive regulation is the localized translation of mRNAs encoding junctional proteins. Chin et al. demonstrated that localized regulation of cell junction mRNAs is required for epithelial cell integrity, meaning that transcripts are transported to junctions and translated on site to supply proteins precisely where needed. Alternative translation initiation can produce synaptic organizer proteoforms with distinct localization, further diversifying the pool of proteins available for junctional targeting. This spatial control ensures rapid and efficient protein delivery to cell-cell junctions.
Trafficking and anchoring of proteins to junctions
In simple terms: Newly made proteins are moved to the junction and locked in place.
After synthesis, junctional proteins must be trafficked to the cell-cell contact and anchored. While the exact trafficking machinery is context-dependent, the requirement for localized mRNA regulation implies that proteins are delivered co-translationally or via vesicular transport to the junctional domain. In inhibitory synapses, astrocyte-secreted neurocan controls formation and function, likely by promoting the localization of synaptic proteins to the junction. This step ensures that proteins accumulate at the correct membrane subdomain.
Maintenance and dynamic remodeling
In simple terms: Junctions are constantly refreshed and can be remodeled.
Positive regulation is not a one-time event; it includes ongoing processes that maintain protein levels at junctions and allow remodeling. In sepsis, neutrophil extracellular traps impair intestinal barrier functions by regulating TLR9-mediated endoplasmic reticulum stress, which can disrupt junctional protein localization and barrier integrity. Conversely, in cancer, junctional proteins like claudin18.2 are targeted by therapeutic antibodies, and their localization may influence drug efficacy. Thus, dynamic regulation of protein localization at junctions is essential for both normal physiology and disease.
Key Genes Involved in GO:0150107 positive regulation of protein localization to cell-cell junction
The following genes and proteins are involved in positive regulation of protein localization to cell-cell junction, based on verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CLDN18 | Claudin18.2 is a junctional protein and therapeutic target in gastric cancer | Zolbetuximab targets CLDN18.2; localization to junctions affects therapy |
| TLR9 | Toll-like receptor 9 mediates ER stress in sepsis, impairing intestinal barrier | Links innate immune signaling to junctional protein localization |
| NCAN | Neurocan is an astrocyte-secreted proteoglycan controlling inhibitory synapse formation | Regulates specialized cell-cell junction assembly in the brain |
| HCN1 | Hyperpolarization-activated cyclic nucleotide-gated channel enhances GABA release | Modulates synaptic junction function in parvalbumin-positive interneurons |
| GABAA receptors | Mediate inhibitory synaptic transmission at junctions | Targets of neurocan regulation at inhibitory synapses |
| Cadherins | Core adhesion proteins at adherens junctions | Localized mRNA regulation ensures their delivery to junctions |
| Catenins | Link cadherins to the cytoskeleton at junctions | Essential for junction assembly and stability |
| Occludin | Tight junction protein maintaining barrier function | Disrupted in sepsis-associated barrier dysfunction |
| ZO-1 | Scaffold protein linking tight junction proteins to actin | Marker of junctional integrity |
| Claudins | Family of tight junction proteins controlling paracellular permeability | CLDN18.2 is a drug target in cancer |
| ER stress sensors | PERK, ATF6, IRE1 mediate unfolded protein response | TLR9-mediated ER stress impairs junctional protein localization |
| Synaptic organizers | Proteoforms with distinct localization regulate synapse formation | Alternative translation initiation diversifies junctional proteins |
| Neurocan | Astrocyte-secreted factor controlling inhibitory synapse formation | Regulates specialized cell-cell junctions |
| Disitamab vedotin target | HER2-related pathway in cancer | Antibody-drug conjugate approved for cancer therapy |
| Zolbetuximab target | Claudin18.2 | Monoclonal antibody for gastric/gastroesophageal junction cancer |
| PV interneurons markers | Parvalbumin-positive interneurons | HCN1 enhances GABA release at their synapses |
| Cell junction mRNAs | Transcripts localized to junctions | Their localized regulation is required for epithelial integrity |
How Is positive regulation of protein localization to cell-cell junction Regulated?
The process of positive regulation of protein localization to cell-cell junction is itself regulated at multiple levels. Localized mRNA regulation is a key control point, as cell junction mRNAs must be transported and translated on site to maintain epithelial integrity. Signaling through TLR9 and the endoplasmic reticulum stress pathway can impair junctional protein localization, as seen in sepsis where neutrophil extracellular traps disrupt intestinal barrier function. Astrocyte-secreted neurocan provides an extracellular regulatory cue for inhibitory synapse formation, a specialized junction. Additionally, alternative translation initiation generates proteoforms with distinct localization, adding another layer of regulation. These mechanisms ensure that protein delivery to junctions is tightly controlled in response to physiological and pathological stimuli.
positive regulation of protein localization to cell-cell junction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR9 | Sepsis-associated intestinal barrier dysfunction | Knockout mice or intestinal epithelial cell lines with TLR9 KO |
| CLDN18 | Gastric or gastroesophageal junction cancer | CLDN18.2 overexpression in cancer cell lines for drug testing |
| NCAN | Synaptic disorders, inhibitory synapse dysfunction | Neurocan knockout or knockdown in astrocyte-neuron co-cultures |
| HCN1 | Epilepsy, neural circuit disorders | HCN1 knockout or point mutation in PV interneurons |
| ER stress sensors | Inflammatory bowel disease, sepsis | Knockout of PERK/ATF6/IRE1 in epithelial cells |
Sepsis and intestinal barrier dysfunction
In sepsis, neutrophil extracellular traps impair intestinal barrier functions by regulating TLR9-mediated endoplasmic reticulum stress. This pathway disrupts the localization of junctional proteins, leading to loss of epithelial integrity. The study by Sun et al. highlights how inflammatory signals can negatively impact positive regulation of protein localization to cell-cell junction, contributing to disease pathogenesis.
Cancer and junctional targets
Claudin18.2 is a junctional protein that is overexpressed in gastric and gastroesophageal junction cancer. Zolbetuximab, a monoclonal antibody against claudin18.2, has shown clinical benefit, and its efficacy depends on the localization of the target protein at cell-cell junctions. Similarly, disitamab vedotin is an approved antibody-drug conjugate for cancer therapy, illustrating the therapeutic relevance of junctional proteins. Thus, positive regulation of protein localization to cell-cell junction is directly linked to cancer treatment.
Synaptic junctions and neurological disorders
Astrocyte-secreted neurocan controls inhibitory synapse formation and function, a specialized form of cell-cell junction. HCN1 channels enhance evoked GABA release from parvalbumin-positive interneurons, further modulating synaptic junction efficacy. Alternative translation initiation produces synaptic organizer proteoforms with distinct localization, which can impact synapse formation. Dysregulation of these processes may contribute to neurological and psychiatric disorders.
From positive regulation of protein localization to cell-cell junction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate junctional protein localization? | CRISPR knockout in epithelial cell lines |
| Does a specific mutation affect protein targeting to junctions? | Point mutation knock-in using CRISPR |
| Can a tagged version of the protein rescue junctional localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression of gene Y enhance junction assembly? | Overexpression via lentiviral or CRISPR activation |
| What mRNAs are locally translated at junctions? | Knockout of RNA-binding proteins followed by imaging |
| How does neurocan affect inhibitory synapse formation? | Neurocan knockout or overexpression in astrocyte-neuron co-cultures |
How to Study the positive regulation of protein localization to cell-cell junction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Confocal microscopy | Localization of fluorescently tagged junctional proteins | Assessing protein accumulation at cell-cell junctions |
| Single-molecule FISH | Localization of specific mRNAs at junctions | Detecting localized transcripts |
| Ribosome profiling | Translation efficiency of junctional mRNAs | Identifying locally translated proteins |
| TEER assay | Epithelial barrier integrity | Functional readout of junction assembly |
| CRISPR screen | Genes regulating junctional protein localization | Discovery of novel regulators |
| Co-immunoprecipitation | Protein-protein interactions at junctions | Identifying junctional complexes |
| Live-cell imaging | Dynamic delivery of proteins to junctions | Tracking real-time localization |
Imaging of junctional protein localization
Fluorescence microscopy, including confocal and super-resolution imaging, is used to visualize the localization of proteins at cell-cell junctions. Tagged proteins or specific antibodies can reveal whether a protein accumulates at junctions under different conditions. Live-cell imaging allows dynamic tracking of protein delivery to junctions.
Localized mRNA analysis
To study localized translation, researchers can use single-molecule FISH to detect junctional mRNAs, or ribosome profiling of junctional fractions. Chin et al. demonstrated that localized regulation of cell junction mRNAs is required for epithelial integrity, highlighting the importance of transcript localization. Alternative translation initiation can be studied by polysome profiling and proteoform-specific antibodies.
CRISPR-based genetic screens
CRISPR knockout or activation screens can identify genes that positively regulate protein localization to cell-cell junctions. For example, a screen could use a junctional protein fused to a fluorescent reporter and select for cells with altered junctional signal. Such screens can uncover novel regulators and therapeutic targets.
Barrier function assays
Transepithelial electrical resistance (TEER) and permeability assays measure epithelial barrier integrity, which depends on proper junctional protein localization. These assays are used in sepsis models to assess barrier dysfunction. Combining barrier assays with imaging provides functional validation of junctional regulation.
How CRISPR Can Be Used to Study GO:0150107 positive regulation of protein localization to cell-cell junction
Knockout
CRISPR knockout is used to delete genes suspected of regulating protein localization to cell-cell junctions. For example, knocking out TLR9 in intestinal epithelial cells can test its role in sepsis-induced barrier dysfunction. Knockout of candidate genes followed by imaging of junctional markers reveals whether the gene is required for positive regulation.
Point Mutation
Point mutations can be introduced to dissect specific residues or domains involved in junctional targeting. For instance, mutating phosphorylation sites on a junctional protein can test their role in localization. CRISPR base editing or homology-directed repair enables precise point mutations in endogenous genes.
Knock-in
Knock-in of fluorescent or epitope tags allows visualization and purification of endogenous junctional proteins. Tagging a protein such as claudin18.2 can reveal its localization dynamics at cell-cell junctions. Knock-in models are also useful for studying proteoforms generated by alternative translation initiation.
Overexpression
Overexpression of a gene of interest can test whether it is sufficient to enhance protein localization to junctions. For example, overexpressing neurocan in astrocytes may increase inhibitory synapse formation. CRISPR activation (CRISPRa) can achieve controlled overexpression without exogenous constructs.
How EDITGENE Supports positive regulation of protein localization to cell-cell junction Research
Researchers studying positive regulation of protein localization to cell-cell junction-related genes often need to determine whether a candidate gene is causally involved in junction assembly, maintenance, or disease-associated dysfunction. EDITGENE provides comprehensive CRISPR-based services to accelerate this research, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of protein localization to cell-cell junction research.
Frequently Asked Questions About positive regulation of protein localization to cell-cell junction
What is GO:0150107?
GO:0150107 is the Gene Ontology term for positive regulation of protein localization to cell-cell junction, defined as any process that activates or increases the frequency, rate or extent of protein localization to cell-cell junction.
What genes are involved in positive regulation of protein localization to cell-cell junction?
Genes such as CLDN18, TLR9, NCAN, and HCN1 have been implicated in processes related to junctional protein localization.
How is protein localization to cell-cell junctions regulated?
It is regulated by localized mRNA translation, signaling pathways such as TLR9-mediated ER stress, and extracellular factors like neurocan.
What diseases are associated with defects in junctional protein localization?
Diseases include sepsis-associated intestinal barrier dysfunction, gastric cancer, and synaptic disorders.
What methods are used to study protein localization to cell-cell junctions?
Common methods include fluorescence microscopy, single-molecule FISH, ribosome profiling, TEER assays, and CRISPR screens.
How can CRISPR be used to study GO:0150107?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of genes regulating junctional protein localization.
What is the role of claudin18.2 in cell-cell junctions?
Claudin18.2 is a junctional protein and a therapeutic target in gastric cancer, with its localization affecting drug efficacy.
How does neurocan affect cell-cell junctions?
Astrocyte-secreted neurocan controls inhibitory synapse formation and function, a specialized cell-cell junction process.
Can localized mRNA translation regulate junctional proteins?
Yes, localized regulation of cell junction mRNAs is required for epithelial cell integrity, ensuring proteins are synthesized at the junction.
What experimental models are available for studying junctional protein localization?
Models include CRISPR knockout cell lines, tagged knock-in cells, overexpression systems, and animal models such as neurocan knockout mice.
Conclusion
GO:0150107, positive regulation of protein localization to cell-cell junction, is a fundamental biological process that ensures proteins are delivered to intercellular contacts with precise spatial and temporal control. Its mechanisms involve localized mRNA translation, signaling pathways, and extracellular cues, and its dysregulation is linked to sepsis, cancer, and synaptic disorders. CRISPR-based models and advanced imaging methods are powerful tools to dissect this process and identify therapeutic targets. EDITGENE offers comprehensive services to support research on this important GO term.
References
- 1. Irala D et al.. 2024. Astrocyte-secreted neurocan controls inhibitory synapse formation and function.. Neuron 112(10):1657-1675.e10 PMID: 38574730
- 2. Kubota Y et al.. 2024. Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer.. Ther Adv Med Oncol 16:17588359231217967 PMID: 38188462
- 4. Sun S et al.. 2021. Neutrophil extracellular traps impair intestinal barrier functions in sepsis by regulating TLR9-mediated endoplasmic reticulum stress pathway.. Cell Death Dis 12(6):606 PMID: 34117211
- 5. Chin A et al.. 2026. Localized regulation of cell junction mRNAs is required for epithelial cell integrity.. RNA 32(5):635-653 PMID: 41535088
- 6. Deeks ED. 2021. Disitamab Vedotin: First Approval.. Drugs 81(16):1929-1935 PMID: 34661865
- 7. Lee PJ et al.. 2024. Alternative translation initiation produces synaptic organizer proteoforms with distinct localization and functions.. Mol Cell 84(20):3967-3978.e8 PMID: 39317199
- 8. Buss EW et al.. 2024. HCN1 hyperpolarization-activated cyclic nucleotide-gated channels enhance evoked GABA release from parvalbumin-positive interneurons.. Proc Natl Acad Sci U S A 121(42):e2319246121 PMID: 39378096
